Rare Dual-Mutation GIST Responds to Targeted Therapy, Challenging Established Tumor Biology
May 6, 2026
“Gastrointestinal stromal tumors (GISTs) are molecularly defined by oncogenic alterations that predict clinical behavior and response to therapy.” BUFFALO, NY - May 6, 2026 – A new case report was… read more
